Lipid Panel

Cleveland HeartLab L, Lipids, Test


CPT Code: 80061; (and 83721 if Direct LDL performed)
Order Code:

Lipid Panel: C906 (includes Total Cholesterol, Triglyceride, Direct HDL, Calculated LDL and Non-HDL Cholesterol)
Lipid Panel and Direct LDL Cholesterol: C909 (includes Total Cholesterol, Triglyceride, Direct HDL, Non-HDL Cholesterol and Direct LDL if Triglyceride is greater than 400 mg/dL.)

Refer to individual tests for assay information.
ABN Requirement:  No
Specimen: Serum
Volume: 2.0 mL
Minimum Volume: 1.0 mL
Container: Gel-barrier tube (SST, Tiger Top)


  1. Collect and label sample according to standard protocols.
  2. Gently invert tube 5 times immediately after draw. DO NOT SHAKE.
  3. Allow blood to clot 30 minutes.
  4. Centrifuge at 1300 rcf for 10 minutes.

Patient Preparation: Fasting is preferred

Transport: Store serum at 2° to 8°C after collection and ship the same day per packaging instructions provided with the Cleveland HeartLab, Inc. shipping box.


Ambient (15-25°C): not acceptable
Refrigerated (2-8°C): 7 days
Frozen (-20°C): 14 days
Deep Frozen (-70°): 30 days 

Causes of Rejection: Specimens other than serum; improper labeling; samples not stored properly; samples older than stability limits.

Methodology: Photometric

Turn Around Time: 1 to 3 days

Relative Risk:

TestAgeLow Risk
Moderate Risk
High Risk
Cholesterol0-19 years<170170-199>199
20-24 years<190190-224>224
≥25 years<200200-239>239
Triglyceride0-9 years<7575-99>99
10-19 years<9090-129>129
20-24 years<115115-149>149
≥25 years<150150-199>199
HDL, Direct0-19 years>45N/A<50
≥20 years, Female>49N/A<50
≥20 years, Male>39N/A<40
LDL, Calculated0-19 years<110110-129>129
20-24 years<120120-159>159
≥25 years<100100-129>129
Non-HDL Cholesterol0-19 years<120120-144>144
20-24 years<150150-189>189
≥25 years<130130-159>159
LDL, Direct0-19 years<110110-129>129
20-24 years<120120-159>159
≥25 years<100100-129>129

Use: The lipid panel is used, along with other tests, during routine assessment to determine an individual’s risk of cardiovascular disease. A lipid panel can also be used to monitor the efficacy of lifestyle interventions or medications.

Limitations: Intralipid causes artificially high LDL cholesterol results. In some patients with abnormal liver function, the LDL-cholesterol result is significantly negatively biased versus beta quantification results. In very rare cases gammopathy may cause unreliable results.

Additional Information: Adults without other risk factors for heart disease should receive a lipid panel once every five years. Individuals who have had an abnormal lipid panel, or those who have other cardiovascular risk factors, may be tested more frequently.